Interleukins in chronic liver disease: lessons learned from experimental mouse models
about
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisHepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepRestoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosisFibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyIL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease ProgressionHow Inflammation Impinges on NAFLD: A Role for Kupffer CellsHuman Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation.Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies.Fish gut-liver immunity during homeostasis or inflammation revealed by integrative transcriptome and proteome studies.Adipokines in Liver Cirrhosis.Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis.Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma.Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice.Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice.Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.IL-33/ST2 Axis in Organ FibrosisIL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
P2860
Q26768588-25440C65-9E13-44F4-BE89-3AECF6C79563Q26771518-746CC4A9-B44E-4ED8-80E2-2940BCC43C8CQ26782048-EF3EED31-959C-4E32-8B29-ECDA5B8909FFQ26801150-7E09DA8A-049A-4BD6-8CDC-17E73D22E6D8Q27025620-691E103E-DAD3-4CE6-8447-29B6C6A1C9D8Q28083001-4FB1D1C5-A89F-44D3-B4A8-7707BE3E7AB7Q33722100-D6FA1232-C04A-4667-A002-7340740A1ED7Q35667925-BAC598C2-EE46-4DBE-8636-4E19D1B84A42Q36499677-6C790607-1EA4-485B-8DEC-C51937E071BEQ36870030-7FE591BE-1D38-47CF-9200-1DD17BBBAD0DQ37390449-7E05B839-18FA-41E3-A0A0-F1642E127A3FQ39404643-0B5855AD-869B-4197-BA5E-85F4794014F8Q41050095-430C658A-C019-4C04-902C-0D6EB1EA17B1Q41500577-A158754D-BFB0-4FFE-A725-0ECFE6D1BB99Q45863196-86B6253D-2566-41B3-A182-9F8B96421F47Q47554770-F7FCBB77-78D5-43AA-97ED-2472C7417029Q49959033-3038DB5F-71AE-4F5D-B4FA-2F95D7A38086Q52592866-8E088093-C44C-4DE1-908B-47F4321DBF90Q55208795-71DA19FC-FAF9-450D-B9CA-40F0408A4173Q58566658-82F4AE4C-0111-40C4-9F40-503E65953A2DQ58869848-DB5CC63F-B9EF-4BEF-AC15-6E8DFCDC10DD
P2860
Interleukins in chronic liver disease: lessons learned from experimental mouse models
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@ast
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@en
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@nl
type
label
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@ast
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@en
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@nl
prefLabel
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@ast
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@en
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@nl
P2860
P356
P1476
Interleukins in chronic liver disease: lessons learned from experimental mouse models
@en
P2093
Frank Tacke
P2860
P304
P356
10.2147/CEG.S43737
P407
P577
2014-09-01T00:00:00Z